April 30, 2007 03:00 PM Eastern Daylight Time
Cord Blood Registry® Releases an Increasing Number of Stem Cell Samples to Treat a Broad Range of Medical Conditions
Company Also Achieves Record-Setting Enrollment Monthsin the First Quarter of 2007


SAN BRUNO, Calif.--(BUSINESS WIRE)--Cord Blood Registry® (CBR®), the
world's largest and most experienced cord blood stem cell bank, today
announced that it has released a total of five stem cell samples in the first quarter of the year for transplant or infusion. Three of the cases are individuals who will require their own cord blood stem cells for autologous infusions for cerebral palsy, type I diabetes, and a rare autoimmune disorder related to autism.

The additional two samples were released for use by a sibling in each family: one to treat acute myeloid leukemia and the other to treat a serious blood disease, Diamond Blackfan anemia. In addition to the samples released for transplants, the company received five additional requests to release measured samples, also known as aliquots, to be used for pre-transplantation analysis.

"The growing number of requests CBR is receiving for release of samples to the families who stored them is an important indication that the medical community is increasingly using autologous and genetically- related cord blood stem cells to help save lives," said David Harris, Ph.D., CBR scientific director and professor of immunology at the University of Arizona. "It is particularly encouraging to see the benefits of cord blood stem cells extend to patients with diverse unmet medical needs. This includes a number of
regenerative medicine therapies which require a patient's own cells."

According to the National Marrow Donor Program, the number of transplants using cord blood as a source of stem cells will surpass those using bone marrow later this year.

CBR also reported today that it continues to outpace the industry in the total number of enrollments and achieved its highest enrollment months ever during the quarter.
...................

More : http://home.businesswire.com/portal/...15&newsLang=en